WallStreetZenWallStreetZen

NASDAQ: HOLX
Hologic Inc Stock

$78.46+1.12 (+1.45%)
Updated Jul 16, 2024
HOLX Price
$78.46
Fair Value Price
$110.09
Market Cap
$18.31B
52 Week Low
$64.02
52 Week High
$82.45
P/E
40.03x
P/B
3.78x
P/S
4.64x
PEG
1.16x
Dividend Yield
N/A
Revenue
$3.96B
Earnings
$466.50M
Gross Margin
49.9%
Operating Margin
17.03%
Profit Margin
11.8%
Debt to Equity
0.8
Operating Cash Flow
$1B
Beta
0.78
Next Earnings
Jul 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

HOLX Overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HOLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HOLX ($78.46) is undervalued by 28.73% relative to our estimate of its Fair Value price of $110.09 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HOLX ($78.46) is significantly undervalued by 28.73% relative to our estimate of its Fair Value price of $110.09 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HOLX ($78.46) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HOLX due diligence checks available for Premium users.

Be the first to know about important HOLX news, forecast changes, insider trades & much more!

HOLX News

Valuation

HOLX fair value

Fair Value of HOLX stock based on Discounted Cash Flow (DCF)
Price
$78.46
Fair Value
$110.09
Undervalued by
28.73%
HOLX ($78.46) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HOLX ($78.46) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HOLX ($78.46) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HOLX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
40.03x
Industry
56.79x
Market
31.71x
HOLX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HOLX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HOLX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.78x
Industry
3.71x
HOLX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HOLX price to earnings growth (PEG)

For valuing profitable companies with growth potential
HOLX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

HOLX's financial health

Profit margin

Revenue
$1.0B
Net Income
$169.9M
Profit Margin
16.7%
HOLX's Earnings (EBIT) of $674.60M... subscribe to Premium to read more.
Interest Coverage Financials
HOLX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$8.7B
Liabilities
$3.9B
Debt to equity
0.8
HOLX's short-term assets ($3.79B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HOLX's short-term assets ($3.79B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HOLX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HOLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$292.4M
Investing
-$38.5M
Financing
-$4.2M
HOLX's operating cash flow ($1.10B)... subscribe to Premium to read more.
Debt Coverage Financials

HOLX vs Medical Stocks

TickerMarket Cap1d %P/EP/B
HOLX$18.31B+1.45%40.03x3.78x
BAX$18.11B+4.62%6.80x2.22x
COO$17.95B+1.66%52.56x2.30x
WST$23.97B+2.81%42.91x8.94x
TFX$10.80B+4.29%36.57x2.40x

Hologic Stock FAQ

What is Hologic's quote symbol?

(NASDAQ: HOLX) Hologic trades on the NASDAQ under the ticker symbol HOLX. Hologic stock quotes can also be displayed as NASDAQ: HOLX.

If you're new to stock investing, here's how to buy Hologic stock.

What is the 52 week high and low for Hologic (NASDAQ: HOLX)?

(NASDAQ: HOLX) Hologic's 52-week high was $82.45, and its 52-week low was $64.02. It is currently -4.84% from its 52-week high and 22.56% from its 52-week low.

How much is Hologic stock worth today?

(NASDAQ: HOLX) Hologic currently has 233,376,948 outstanding shares. With Hologic stock trading at $78.46 per share, the total value of Hologic stock (market capitalization) is $18.31B.

Hologic stock was originally listed at a price of $5.17 in Dec 31, 1997. If you had invested in Hologic stock at $5.17, your return over the last 26 years would have been 1,416.72%, for an annualized return of 11.02% (not including any dividends or dividend reinvestments).

How much is Hologic's stock price per share?

(NASDAQ: HOLX) Hologic stock price per share is $78.46 today (as of Jul 16, 2024).

What is Hologic's Market Cap?

(NASDAQ: HOLX) Hologic's market cap is $18.31B, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hologic's market cap is calculated by multiplying HOLX's current stock price of $78.46 by HOLX's total outstanding shares of 233,376,948.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.